İbrahim Günay

719 total citations
15 papers, 533 citations indexed

About

İbrahim Günay is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, İbrahim Günay has authored 15 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 3 papers in Neurology. Recurrent topics in İbrahim Günay's work include Dementia and Cognitive Impairment Research (8 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (4 papers). İbrahim Günay is often cited by papers focused on Dementia and Cognitive Impairment Research (8 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (4 papers). İbrahim Günay collaborates with scholars based in United States, Switzerland and Germany. İbrahim Günay's co-authors include David L. Sultzer, Kevin F. Gray, Michael E. Mahler, M. Andrew Berisford, Barbara Koumaras, Steven G. Potkin, Douglas I. Katz, David B. Arciniegas, Dario Mirski and Jonathan Silver and has published in prestigious journals such as Neurology, Journal of the American Geriatrics Society and The Journal of Clinical Psychiatry.

In The Last Decade

İbrahim Günay

15 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
İbrahim Günay United States	13	300	157	125	101	82	15	533
Dario Mirski United States	16	421 1.4×	172 1.1×	100 0.8×	80 0.8×	74 0.9×	19	628
H. M. Emrich Germany	13	215 0.7×	86 0.5×	77 0.6×	59 0.6×	80 1.0×	27	542
Donald R. Kanter United States	13	354 1.2×	124 0.8×	56 0.4×	56 0.6×	109 1.3×	17	631
Eugene H. Makela United States	12	225 0.8×	84 0.5×	72 0.6×	64 0.6×	70 0.9×	21	529
Louise Carton France	11	209 0.7×	68 0.4×	90 0.7×	40 0.4×	83 1.0×	32	487
Erik Bertoletti Italy	10	252 0.8×	64 0.4×	38 0.3×	27 0.3×	29 0.4×	17	441
Ashok Seshadri United States	11	166 0.6×	96 0.6×	31 0.2×	37 0.4×	71 0.9×	18	467
W. Alexander Morton United States	10	331 1.1×	110 0.7×	41 0.3×	54 0.5×	119 1.5×	13	595
S. De Risio Italy	16	137 0.5×	157 1.0×	58 0.5×	78 0.8×	158 1.9×	26	625
A.M. Burakov Russia	12	107 0.4×	240 1.5×	129 1.0×	275 2.7×	143 1.7×	21	845

Countries citing papers authored by İbrahim Günay

Since Specialization

Citations

This map shows the geographic impact of İbrahim Günay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İbrahim Günay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İbrahim Günay more than expected).

Fields of papers citing papers by İbrahim Günay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İbrahim Günay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İbrahim Günay. The network helps show where İbrahim Günay may publish in the future.

Co-authorship network of co-authors of İbrahim Günay

This figure shows the co-authorship network connecting the top 25 collaborators of İbrahim Günay. A scholar is included among the top collaborators of İbrahim Günay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İbrahim Günay. İbrahim Günay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Günay, İbrahim, et al.. (2020). Tıp Fakültesi Son Sınıf Öğrencilerinin Ülkemizdeki Aşı Reddi Hakkındaki Düşünceleri. 30(3). 133–139. 4 indexed citations

2.

Silver, Jonathan, Barbara Koumaras, Xiangyi Meng, et al.. (2009). Long-term effects of rivastigmine capsules in patients with traumatic brain injury. Brain Injury. 23(2). 123–132. 45 indexed citations

3.

Figiel, Gary S., et al.. (2008). Long-Term Safety and Tolerability of Rivastigmine in Patients With Alzheimer's Disease Switched From Donepezil. The Primary Care Companion to The Journal of Clinical Psychiatry. 10(5). 363–367. 5 indexed citations

4.

Riepe, Matthias W., et al.. (2007). Domain-Specific Improvement of Cognition on Memantine in Patients with Alzheimer’s Disease Treated with Rivastigmine. Dementia and Geriatric Cognitive Disorders. 23(5). 301–306. 24 indexed citations

5.

Potkin, Steven G., Gus Alva, İbrahim Günay, et al.. (2006). A Pilot Study Evaluating the Efficacy and Safety of Rivastigmine in Patients with Mixed Dementia. Drugs & Aging. 23(3). 241–249. 14 indexed citations

6.

Riepe, Matthias W., et al.. (2006). Adding Memantine to Rivastigmine Therapy in Patients With Mild-to-Moderate Alzheimer's Disease. The Primary Care Companion For CNS Disorders. 8(5). 258–63. 25 indexed citations

7.

Silver, Jonathan, Barbara Koumaras, Dario Mirski, et al.. (2006). Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 67(5). 748–755. 87 indexed citations

8.

Edwards, Keith R., Barbara Koumaras, Michael Chen, İbrahim Günay, & Dario Mirski. (2005). Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing??Home Patients with Alzheimer???s Disease. Clinical Drug Investigation. 25(8). 507–515. 15 indexed citations

9.

Glick, Ira D., et al.. (2004). Patterns of Concomitant Psychotropic Medication Use During a 2-Year Study Comparing Clozapine and Olanzapine for the Prevention of Suicidal Behavior. The Journal of Clinical Psychiatry. 65(5). 679–685. 34 indexed citations

10.

Leuchter, Andrew F., et al.. (2004). Pretreatment Neurophysiologic Function and ECT Response in Depression. Journal of Ect. 20(3). 142–144. 12 indexed citations

11.

Sultzer, David L., et al.. (2001). Does Behavioral Improvement with Haloperidol or Trazodone Treatment Depend on Psychosis or Mood Symptoms in Patients with Dementia?. Journal of the American Geriatrics Society. 49(10). 1294–1300. 36 indexed citations

12.

Sultzer, David L., Kevin F. Gray, İbrahim Günay, M. Andrew Berisford, & Michael E. Mahler. (1997). A Double-Blind Comparison of Trazodone and Haloperidol for Treatment of Agitation in Patients With Dementia. American Journal of Geriatric Psychiatry. 5(1). 60–69. 109 indexed citations

13.

Rodríguez, Fernando López, et al.. (1997). Obsessive Compulsive Disorder in a Woman with Left Basal Ganglia Infarct: A Case Report. Behavioural Neurology. 10(2-3). 101–103. 14 indexed citations

14.

Sultzer, David L., Kevin F. Gray, İbrahim Günay, M. Andrew Berisford, & Michael E. Mahler. (1997). A Double-Blind Comparison of Trazodone and Haloperidol for Treatment of Agitation in Patients With Dementia. American Journal of Geriatric Psychiatry. 5(1). 60–69. 90 indexed citations

15.

Sultzer, David L., M. Andrew Berisford, & İbrahim Günay. (1995). The Neurobehavioral Rating Scale: Reliability in patients with dementia. Journal of Psychiatric Research. 29(3). 185–191. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact